| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60.9M | +50.3% | +36.5% |
| Cost of Revenue | $56.0M | +55.4% | +48.8% |
| Gross Profit | $4.9M | +9.3% | -29.9% |
| R&D Expense | $3.9M | +6.9% | +12.4% |
| SG&A Expense | $3.9M | +15.6% | +39.3% |
| Operating Income | -$4.0M | -14.3% | -387.2% |
| Interest Expense | $299K | -9.7% | +9.0% |
| Pre-tax Income | $1.9M | +156.5% | +648.4% |
| Income Tax | -$184K | — | -154.2% |
| Net Income | $2.7M | +186.3% | — |
| EPS (Basic) | $0.03 | +200.0% | — |
| EPS (Diluted) | $0.03 | +200.0% | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.5M | +84.4% | +0.3% |
| Accounts Receivable | $47.8M | +37.9% | +36.9% |
| Inventory | $34.5M | -7.9% | +44.1% |
| Current Assets | $157.7M | +9.9% | +20.9% |
| Total Assets | $363.9M | +9.2% | +24.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.7M | — | — |
| Capital Expenditures | $30.9M | — | — |
| Investing Cash Flow | -$29.1M | — | — |
| Financing Cash Flow | $10.2M | — | — |
| Free Cash Flow | -$12.2M | — | — |
| $228.0M |
| +14.3% |
| +47.8% |
| Long-term Debt | $4.8M | -2.3% | — |
| Total Liabilities | $245.4M | +13.0% | +50.5% |
| Stockholders' Equity | $121.4M | +2.7% | -7.4% |